Delayed Prostate Cancer Therapy Baltimore MD

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Katherine Hanna Tkaczuk, MD
(410) 328-2565
22 S Greene St
Baltimore, MD
Specialties
Internal Medicine, Medical Oncology
Gender
Female
Education
Medical School: Akademia Med We Wroclawiu Im Piastow Slaskich, Wroclaw, Poland
Graduation Year: 1984
Hospital
Hospital: University Of Maryland Med Sys, Baltimore, Md; Veterans Affairs Med Ctr, Baltimore, Md
Group Practice: University Of Maryland Cancer

Data Provided by:
Susan B Kesmodel
(410) 328-7320
22 S Greene St
Baltimore, MD
Specialty
Surgical Oncology

Data Provided by:
Debra Elaine Freeman, MD
(904) 395-0651
22 S Greene St
Baltimore, MD
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1987

Data Provided by:
Ronald Benjamin Gartenhaus
(410) 328-5793
22 S Greene St
Baltimore, MD
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Martin J Edelman
(410) 328-5793
22 S Greene St
Baltimore, MD
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Dr.Dwight Im
(800) 636-3729
301 Saint Paul Street
Baltimore, MD
Gender
M
Education
Medical School: Umdnj-Robt W Johnson Med Sch
Year of Graduation: 1989
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
4.2, out of 5 based on 5, reviews.

Data Provided by:
Nancy Ann Dawson
(410) 328-2565
22 S Greene St
Baltimore, MD
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Teresa A York, MD
(410) 328-2808
22 S Greene St Rm N5E16
Baltimore, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Ashraf Z Badros, MD
22 S Greene St
Baltimore, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Ain Shams Univ, Fac Of Med, Abbasia, Cairo, Egypt (330-04 Pr 1/71)
Graduation Year: 1985

Data Provided by:
Arif Hussain
(410) 328-5793
22 S Greene St
Baltimore, MD
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com